Serum albumin concentration and heart failure risk: The health, aging, and body composition study

American Heart Journal

Volumn 160, Issue 2, 2010, Pages 279-285

  Gopal, Deepa M ^a   Kalogeropoulos, Andreas P ^b   Georgiopoulou, Vasiliki V ^b   Tang, Wilson W H ^c   Methvin, Amanda ^b   Smith, Andrew L ^b   Bauer, Douglas C ^d   Newman, Anne B ^e   Kim, Lauren ^f   Harris, Tamara B ^f   Kritchevsky, Stephen B ^g   Butler, Javed ^b  

^a BOSTON UNIVERSITY   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g WAKE FOREST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AGING; ALBUMIN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INCIDENCE; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE;

AGED; BODY COMPOSITION; FEMALE; HEART FAILURE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SERUM ALBUMIN; STROKE VOLUME;

EID: 77955463475     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.022     Document Type: Article

References (28)

1. Gillum R.F., and Makuc D.M. Serum albumin, coronary heart disease, and death Am Heart J 123 1992 507 513
2. Klonoff-Cohen H., Barrett-Connor E.L., and Edelstein S.L. Albumin levels as a predictor of mortality in the healthy elderly J Clin Epidemiol 45 1992 207 212
3. Kuller L.H., Eichner J.E., and Orchard T.J. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial Am J Epidemiol 134 1991 1266 1277
4. Phillips A., Shaper A.G., and Whincup P.H. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes Lancet 2 1989 1434 1436
5. Schalk B.W., Visser M., and Bremmer M.A. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam Am J Epidemiol 164 2006 969 977
6. Horwich T.B., Kalantar-Zadeh K., and MacLellan R.W. Albumin levels predict survival in patients with systolic heart failure Am Heart J 155 2008 883 889
7. Butler J., Kalogeropoulos A., and Georgiopoulou V. for the Health ABC Study. Incident heart failure prediction in the elderly: the Health ABC Heart Failure Score Circ Heart Failure 1 2008 125 133
8. Baumgartner R.N., Koehler K.M., and Romero L. Serum albumin is associated with skeletal muscle in elderly men and women Am J Clin Nutr 64 1996 552 558 (Pubitemid 26334233)
9. Rao M., Guo D., and Perianayagam M.C. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients Am J Kidney Dis 45 2005 324 333
10. Yeun J.Y., Levine R.A., and Mantadilok V. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients Am J Kidney Dis 35 2000 469 476
11. Don B.R., and Kaysen G. Serum albumin: relationship to inflammation and nutrition Semin Dial 17 2004 432 437
12. Cesari M., Penninx B.W., and Newman A.B. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study Circulation 108 2003 2317 2322
13. Fried L.P., Borhani N.O., and Enright P. The Cardiovascular Health Study: design and rationale Ann Epidemiol 1 1991 263 276
14. Rodondi N., Newman A.B., and Vittinghoff E. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death Arch Intern Med 165 2005 2460 2466
15. Sauerbrei W., Royston P., and Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building Stat Med 26 2007 5512 5528
16. Fine J.P., and Gray R.J. A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
17. Foley R.N., Parfrey P.S., and Harnett J.D. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease J Am Soc Nephrol 7 1996 728 736
18. Clarke R., Shipley M., and Lewington S. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 1999 341 353
19. Torre-Amione G., Kapadia S., and Benedict C. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD) J Am Coll Cardiol 27 1996 1201 1206
20. Tsutamoto T., Hisanaga T., and Wada A. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure J Am Coll Cardiol 31 1998 391 398
21. Levine B., Kalman J., and Mayer L. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241
22. Raymond R.J., Dehmer G.J., and Theoharides T.C. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction Am Heart J 141 2001 435 438
23. Williams E.S., Shah S.J., and Ali S. C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study Eur J Heart Fail 10 2008 63 69
24. El-Menyar A.A. Cytokines and myocardial dysfunction: state of the art J Card Fail 14 2008 61 74
25. Kuwahara F., Kai H., and Tokuda K. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43 2004 739 745
26. Bahrami H., Bluemke D.A., and Kronmal R. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 51 2008 1775 1783
27. Westermann D., Van Linthout S., and Dhayat S. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy Basic Res Cardiol 102 2007 500 507
28. Van Linthout S., Riad A., and Dhayat N. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy Diabetologia 50 2007 1977 1986